Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × palbociclib × 30 days × Clear all

Phase

Phase 2 18 Phase 3 7 Phase 1 6 Phase 1/2 4 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Tamoxifen 4 Letrozole 4 Anastrozole 4 ribociclib 3 exemestane 3 trametinib 2 dabrafenib 2 atezolizumab 2 Vancomycin 2 Rituximab 2 Nivolumab 2 Ipilimumab 2 Fulvestrant 2 Carboplatin 2 Blood Specimen Collection 2 Bevacizumab 2 toripalimab 1 tislelizumab 1 sofosbuvir-velpatasvir drug combination 1 rozanolixizumab 1 relatlimab 1 ravulizumab 1 radium Ra 223 dichloride 1 pirtobrutinib 1 pembrolizumab 1 pazopanib 1 palbociclib 1 olutasidenib 1 obinutuzumab 1 nirogacestat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07487129 2026-03-23

Clinical and P

Beni-Suef University

Phase 4 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡